Following the second opinion incident that I discussed in part one of this column last week, I want to make it clear that I ...
New York, New York, Sept. 12, 2025 (GLOBE NEWSWIRE) -- AlphaVest Acquisition Corp (the “Company”) today filed a supplement (the “Proxy Supplement”) to its proxy statement dated September 2, 2025, ...
New York, New York, Sept. 12, 2025 (GLOBE NEWSWIRE) -- AlphaVest Acquisition Corp (the "Company”) today filed a supplement (the "Proxy Supplement”) to its proxy statement dated September 2, 2025, ...
[Image courtesy of Elutia] Elutia (Nasdaq:ELUT) announced today that it agreed to sell its bioenvelope technologies to Boston Scientific for $88 million. Gaithersburg, Maryland-based Elutia agreed to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback